Free public records show NovaResp Technologies Inc in 1 of the markets we cover. It is not a key player in our research.
[1] ClinicalTrials.gov, Studies led by NovaResp Technologies Inc or a part of it that are recruiting, about to start or running. Retrieved 13 Nov 2026.
From public registers, not from Acuitas research, with a citation under every number. Each card opens the full list at its source.
2 active studies led by NovaResp Technologies Inc, of 5 in all
Source: ClinicalTrials.gov, Studies with NovaResp Technologies Inc (or a part of it) as lead sponsor; active = recruiting, about to start or running. Retrieved 13 Nov 2026.
Studies NovaResp Technologies Inc leads, by the year they started and their phase
Source: ClinicalTrials.gov, Studies with NovaResp Technologies Inc or a part of it as lead sponsor, by start year (since 2015) and phase. Retrieved 13 Nov 2026.
Markets we cover where free public records show NovaResp Technologies Inc: trials they lead, US approvals or WHO prequalification. Each opens the market's report, with the record counts and their sources.
The topics of the markets NovaResp Technologies Inc is in.
Stories on the topics NovaResp Technologies Inc works in.
170 WHO Member States report the use of traditional medicine. Adaptogens like ashwagandha, rhodiola and…
Read
Depression and anxiety cost the world about US$1 trillion a year. Ashwagandha has some evidence for stress…
Read
About 3 in 10 US adults sleep less than 7 hours. Melatonin helps with jet lag and shift work, but its effect…
ReadSearch all reports for NovaResp Technologies Inc All companies